GT Biopharma, Inc. (GTBP)
0.4589
0.00 (0.00%)
USD |
NASDAQ |
Mar 05, 16:00
0.4589
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Research and Development Expense (Annual) : 3.472M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | 19.10M |
| Lyell Immunopharma, Inc. | 152.28M |
| Geron Corp. | 71.43M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Crinetics Pharmaceuticals, Inc. | 328.17M |